AI-Customized Solution for Universal (Off-the-Shelf) CAR-T

Q: Q: Do engineering 'stealth' features impact the CAR-T's killing potency?

Our AI-driven 'Design-Build-Test-Learn' cycle ensures that stealth edits are placed strategically to avoid interfering with CAR signaling motifs, maintaining high cytotoxicity.

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides AI-Customized Solutions for Universal (Off-the-Shelf) CAR-T to address key challenges in cell therapy development, including high manufacturing costs, prolonged vein-to-vein timelines, and the risk of graft-versus-host disease in allogeneic settings. This service enables the development of high-potency, immune-evasive CAR-T cells that minimize host rejection and reduce patient-specific variability. By integrating AI-driven structural prediction, logic-gated receptor design, and genome engineering, Creative Biolabs accelerates the transition from complex autologous workflows to scalable, standardized off-the-shelf CAR-T therapeutics.

Introduction

Universal CAR-T therapies aim to create standardized, ready-to-use cell products derived from healthy donor cells. Recent studies demonstrate that multiplex gene editing and immune modulation can reduce immune rejection while maintaining antitumor activity. Advances in computational biology and artificial intelligence now enable predictive design of immune-evasive cell products, accelerating development of scalable allogeneic therapies with improved safety and persistence.

Service

Creative Biolabs provides a comprehensive suite of engineering services designed to transform healthy donor T cells into therapeutic assets that are both "invisible" to the host immune system and highly specific to the tumor. We solve the primary barriers of allogeneic therapy and rapid rejection by using AI to identify and knock out endogenous T-cell receptors (TCR) and MHC molecules while simultaneously integrating stealth features.

Immune-Evasion Engineering

AI-guided design strategies identify optimal gene-editing combinations to minimize host immune recognition while preserving T cell functionality. Approaches focus on reducing host-versus-graft rejection and preventing graft-versus-host responses.

AI-Driven CAR Architecture Optimization

Machine learning-assisted structural modeling evaluates CAR domains, signaling modules, and binding fragments to improve target specificity, signaling strength, and persistence.

Multi-Parameter Cellular Engineering

Computational modeling integrates genomic, transcriptomic, and immunological datasets to optimize multiplex gene modifications and regulatory elements that enhance durability and safety.

Translational Development Support

The platform supports candidate selection, experimental validation strategies, and scalability assessments to accelerate progression from discovery to preclinical development.

Discover How We Can Help - Request a Consultation.

What We Can Offer

AI-Guided Immune Compatibility Modeling	Multiplex Gene Editing Design
Predictive algorithms evaluate donor-recipient immune interactions, enabling rational design of immune-evasive cell products with reduced rejection risk.	Computational frameworks assist in selecting optimal gene modification combinations that regulate antigen presentation, immune signaling, and cellular persistence.
CAR Structure Optimization Platform	Systems-Level Immunoengineering Analysis
AI-assisted protein modeling analyzes receptor structure, binding interfaces, and intracellular signaling modules to improve functional stability and therapeutic activity.	Integrated multi-omics datasets support identification of pathways influencing cell persistence, exhaustion resistance, and therapeutic efficacy.

Our Workflow

To initiate a project, clients typically provide target antigen sequences or desired scFv candidates, specific donor cell requirements, and a profile of the target tumor microenvironment.

Workflow of AI-Customized Solutions for Universal (Off-the-shelf) CAR-T. (Creative Biolabs Original)

Final Deliverables include an AI Modeling Report detailing the optimized CAR construct and predicted stealth efficiency, validated universal CAR-T cell lines with confirmed multi-gene knockouts and target specificity, as well as detailed preclinical toxicity profiles and 'Operating Curves' generated through AI-assisted efficacy and side-effect prediction.

Core Benefits

Custom AI-Designed "Stealth" Structures: Using machine learning to predict and develop surface changes that stop the body's immune system from rejecting the cells.
Programmable Logic Control Design: Custom "AND," "OR," and "NOT" logic systems to improve targeting accuracy in mixed solid tumors.
AI-Optimized scFv Affinity Adjustment: Using protein structure modeling tools to maximize tumor binding while reducing the risk of binding to normal cells (known as "on-target, off-tumor" risks).

FAQs

Q: Do engineering "stealth" features impact the CAR-T's killing potency?

A: Our AI-driven "Design-Build-Test-Learn" cycle ensures that stealth edits are placed strategically to avoid interfering with CAR signaling motifs, maintaining high cytotoxicity.

Q: Can your AI platform predict potential side effects like CRS?

A: Yes, we use supervised and unsupervised ML models to analyze cytokine signatures and predict the risk of Grade 4/5 CRS with over 85% sensitivity.

Q: How does your service compare to standard autologous CAR-T?

A: Our universal solutions offer higher accessibility by removing the "one-to-one" manufacturing model, significantly reducing costs and "vein-to-vein" wait times.

Q: Is the "stealth" feature permanent?

A: Since we use genomic editing (knockouts), the stealth characteristics are inherited by daughter cells as the CAR-T population expands in the patient.

Partner with Us

Creative Biolabs offers a world-class platform for AI-Customized Solutions for Universal (Off-the-shelf) CAR-T. By integrating high-fidelity AI structural predictions with precision synthetic biology, we empower our clients to overcome the challenges of solid tumors and manufacturing scalability. From stealth engineering to logic-gate design, we provide the intelligence required to make next-generation cell therapies a reality. Contact our team for more information and to discuss your project.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.